Lyophilized powder, 99% purity, third-party tested
A multicenter study involving 567 subjects with symptomatic DPN who received intravenous Actovegin for 20 days (2000 mg/day), followed by three Actovegin tablets daily (1800 mg/day) or placebo for 140 days, demonstrated efficacy in improving neuropathic symptoms and VPT, with a safety profile similar to that of placebo [78]
Sacks, and Kosali I
Epithalon is currently being researched as a potential drug for Her-2/neu positive breast cancer and in preventing the development of certain types of leukemia and testicular cancer
Many hope these apparent wonder drugs will also treat neurological disorders and potentially substance use disorders, too
For maximum safety, simplicity, and charging ease, a new Auto Charge feature recognizes Smart battery charging parameters as soon as you connect your pack and begins proper charging automatically